Latest debt-to-equity ratio

BioMarin Pharmaceutical Debt-to-equity ratio

Direct answer

BioMarin Pharmaceutical's debt-to-equity ratio is 66.47%.

The verified market snapshot reports 66.47%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.

Get free BioMarin Pharmaceutical email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
66.47%

Explore related company data

View BioMarin Pharmaceutical's market capitalizationView BioMarin Pharmaceutical's p/e ratioView BioMarin Pharmaceutical's price-to-book ratioView BioMarin Pharmaceutical's return on equityView BioMarin Pharmaceutical's dividend yieldView BioMarin Pharmaceutical's 52-week price rangeView BioMarin Pharmaceutical's revenue growthView BioMarin Pharmaceutical's profit marginView all BioMarin Pharmaceutical key metricsReturn to BioMarin Pharmaceutical profile